NCT04276428View on ClinicalTrials.gov

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

November 28, 2020

Study Completion Date

November 28, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY3209590

Administered SC.

DRUG

Insulin Degludec

Administered SC.

Trial Locations (3)

162-0053

Clinical Research Hospital Tokyo, Shinjuku-ku

192-0071

P-one clinic, Hachiōji

232-0064

Yokohama Minoru Clinic, Yokohama

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04276428 - A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter